Cargando…
A new mechanism of trastuzumab resistance in gastric cancer: MACC1 promotes the Warburg effect via activation of the PI3K/AKT signaling pathway
BACKGROUND: Trastuzumab, a humanized antibody targeting HER2, exhibits remarkable therapeutic efficacy against HER2-positive gastric cancer. However, recurrent therapeutic resistance presents revolutionary claims. Warburg effect and AKT signaling pathway was involved in the resistance to trastuzumab...
Autores principales: | Liu, Jing, Pan, Changqie, Guo, Lihong, Wu, Mengwan, Guo, Jing, Peng, Sheng, Wu, Qianying, Zuo, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007850/ https://www.ncbi.nlm.nih.gov/pubmed/27581375 http://dx.doi.org/10.1186/s13045-016-0302-1 |
Ejemplares similares
-
Development of trastuzumab-resistant human gastric carcinoma cell lines and mechanisms of drug resistance
por: Zuo, Qiang, et al.
Publicado: (2015) -
The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer
por: Wu, Mengwan, et al.
Publicado: (2016) -
Everolimus regulates the activity of gemcitabine-resistant pancreatic cancer cells by targeting the Warburg effect via PI3K/AKT/mTOR signaling
por: Cui, Jing, et al.
Publicado: (2021) -
Research on drug resistance mechanism of trastuzumab caused by activation of the PI3K/Akt signaling pathway
por: Chen, Xi, et al.
Publicado: (2013) -
Gastric cancer cells escape metabolic stress via the DLC3/MACC1 axis
por: Lin, Li, et al.
Publicado: (2019)